Clinical Therapeutics/New Technology-Non-Insulin Injectables

Clinical Therapeutics/New Technology-Non-Insulin Injectables

Open Access
Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
Matthew J. Crowley, Darren K. McGuire, Anastasia-Stefania Alexopoulos, Thomas Jon Jensen, Søren Rasmussen, Hans A. Saevereid, Subodh Verma, John B. Buse

Diabetes Care Jul 2020, dc200437; DOI: 10.2337/dc20-0437
You have access
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
Christopher K. Rayner, Linda E. Watson, Liza K. Phillips, Kylie Lange, Michelle J. Bound, Jacqueline Grivell, Tongzhi Wu, Karen L. Jones, Michael Horowitz, Ele Ferrannini, Domenico Tricò, Silvia Frascerra, Andrea Mari, Andrea Natali

Diabetes Care Aug 2020, 43 (8) 1813-1821; DOI: 10.2337/dc20-0190
You have access
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR_Rx Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin Therapy
Erin S. Morgan, Li-Jung Tai, Nguyen C. Pham, Julia K. Overman, Lynnetta M. Watts, Anne Smith, Shiangtung W. Jung, Martin Gajdošík, Martin Krššák, Michael Krebs, Richard S. Geary, Brenda F. Baker, Sanjay Bhanot

Diabetes Care Apr 2019, 42 (4) 585-593; DOI: 10.2337/dc18-1343
Open Access
Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes
Mark L. Hartman, Arun J. Sanyal, Rohit Loomba, Jonathan M. Wilson, Amir Nikooienejad, Ross Bray, Chrisanthi A. Karanikas, Kevin L. Duffin, Deborah A. Robins, Axel Haupt

Diabetes Care Jun 2020, 43 (6) 1352-1355; DOI: 10.2337/dc19-1892
You have access
Lack of Durable Improvements in β-Cell Function Following Withdrawal of Pharmacological Interventions in Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes
The RISE Consortium

Diabetes Care Sep 2019, 42 (9) 1742-1751; DOI: 10.2337/dc19-0556
You have access
A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Maya Fayfman, Rodolfo J. Galindo, Daniel J. Rubin, Dara L. Mize, Isabel Anzola, Maria A. Urrutia, Clementina Ramos, Francisco J. Pasquel, J. Sonya Haw, Priyathama Vellanki, Heqiong Wang, Bonnie S. Albury, Rita Weaver, Saumeth Cardona, Guillermo E. Umpierrez

Diabetes Care Mar 2019, 42 (3) 450-456; DOI: 10.2337/dc18-1760
You have access
Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial
Michael A. Nauck, Marie Louise Muus Ghorbani, Eskil Kreiner, Hans A. Saevereid, John B. Buse, the LEADER Publication Committee on behalf of the LEADER Trial Investigators

Diabetes Care Oct 2019, 42 (10) 1912-1920; DOI: 10.2337/dc19-0415
You have access
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study
Aksam Yassin, Ahmad Haider, Karim S. Haider, Monica Caliber, Gheorghe Doros, Farid Saad, W. Timothy Garvey

Diabetes Care Jun 2019, 42 (6) 1104-1111; DOI: 10.2337/dc18-2388
You have access
Changes in Serum Calcitonin Concentrations, Incidence of Medullary Thyroid Carcinoma, and Impact of Routine Calcitonin Concentration Monitoring in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL)
M. Angelyn Bethel, Rishi A. Patel, Vivian P. Thompson, Peter Merrill, Shelby D. Reed, Yanhong Li, Sara Ahmadi, Brian G. Katona, Stephanie M. Gustavson, Peter Ohman, Nayyar Iqbal, Robert F. Gagel, Adrian F. Hernandez, John B. Buse, Rury R. Holman

Diabetes Care Jun 2019, 42 (6) 1075-1080; DOI: 10.2337/dc18-2028
You have access
Neoplasms Reported With Liraglutide or Placebo in People With Type 2 Diabetes: Results From the LEADER Randomized Trial
Michael A. Nauck, Thomas Jon Jensen, Carina Rosenkilde, Salvatore Calanna, John B. Buse, the LEADER Publication Committee on behalf of the LEADER Trial Investigators

Diabetes Care Aug 2018, 41 (8) 1663-1671; DOI: 10.2337/dc17-1825

Main menu

User menu

Search

Clinical Therapeutics/New Technology-Non-Insulin Injectables

Pages

Navigation

Information

ADA Journals

Other ADA Resources